VALIDATION OF THE SPECTROPHOTOMETRIC PROCEDURE FOR DESLORATADINE ASSAY IN TABLETS APPLYING THE UNCERTAINTY CONCEPT OF THE STATE PHARMACOPOEIA OF UKRAINE
Abstract
Aim. This work aimed to validate an assay procedure for desloratadine tablets by direct spectrophotometric method.
Materials and methods. A pilot-scale batch of the pharmaceutical preparation Alerdez, film-coated tablets containing 5 mg of desloratadine, manufactured by PJSC SIC “Borshchahivskiy CPP”, Ukraine, was used as an object of the study. A UV-Vis spectrophotometer Lambda 25 (Perkin Elmer), analytical balance Mettler Toledo XP 205DR, and class A volumetric apparatus were used in the study. Validation of the procedure was performed following the metrological approach of the State Pharmacopoeia of Ukraine (SPhU), whose requirements for the target uncertainty and bias, which rest on the risk assessment of making incorrect decisions on compliance (a confidence level of 95 %), were translated into criteria for all validation characteristics recommended by ICH. All calculations were made in normalised coordinates. The linearity, accuracy and precision (repeatability) were studied in a single experiment using nine different concentrations that uniformly covered the range of ±30 % from the nominal concentration of desloratadine. For validation of the procedure, an SPhU reference standard of desloratadine was used.
Results. The experiment design and validation characteristics being tested were in full compliance with ICH Q2(R1) recommendations. All performance characteristics conformed to the criteria recommended by the SPhU. Requirements for the target uncertainty (1.6 %) and bias for any systematic source of variation (≤0.51 %, negligible in relation to 1.6 %) were established. The analytical procedure was specific – the absorbance from the placebo solution was insignificant (A %=0.36). The procedure met the requirements for linearity, accuracy, and precision at the repeatability level. The residual standard deviation s0 was 0.34 (≤ 0.84); correlation index Rc was 0.9998 (≥0.9991); intercept а was 0.045 (less than its confidence interval ∆a=1.14). The confidence interval for recovery ∆Z, which was used as a precision estimate, was 0.55 % (less than the target uncertainty). The mean recovery, which was used as an accuracy estimate, statistically insignificantly deviated from 100% (|Zmean ‑ 100| = 0.022 %).
The confidence interval for the intermediate precision ∆intrawas 0.33 % (less than the target uncertainty). The developed analytical procedure was found to be robust.
Conclusions. A spectrophotometric procedure suitable for the assay of desloratadine in film-coated tablets Alerdez with content limits of ±5 % was validated by the SPhU approach.
Downloads
References
Desloratadine (2020). National Center for Biotechnology Information PubChem. Compound Summary for CID 124087. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/Desloratadine
Mohammad, Y., Pragati Kumar, B., Srinivas, R., Rehana, S. K. (2010). New UV spectrophotometric method for the determination of desloratadine in bulk and tablet dosage forms. Journal of Chemical and Pharmaceutical Sciences, 3 (4), 241–243.
Validation of Analytical Procedures: Text and Methodology Q2R1 Current Step 4 version (2005). The International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline, 17.
Technical guide for the Elaboration of Monographs (2015). European Directorate for the Quality of Medicines & HealthCare. Strasbourg: EDQM, 74.
<1225> Validation of compendial procedures (2017). The United States Pharmacopeia 40. Rockville: The United States Pharmacopeial Convention, 1780–1787.
Supplementary guidelines on good manufacturing practices: validation (2006). Technical Report Series. No. 937. Geneva: World Health Organization, 107–178.
Koch, W. F., Hauck, W. W., de Mars, S. S., Williams, R. L. (2010). Measurement Science for Food and Drug Monographs: Toward a Global System. Pharmaceutical Research, 27 (7), 1203–1207. doi: http://doi.org/10.1007/s11095-010-0118-6
Martin, G. P., Barnett, K., Burgess, C., Curry, P. D., Ermer, J., Gratzl, G. S. et. al. (2013). Lifecycle Management of Analytical Procedures: Method Development, Procedure Performance Qualification, and Procedure Performance Verification. Pharmacopeial Forum, 39 (5). Available at: https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/revisions/lifecycle_pdf.pdf
Argentine, M., Barnett, K., Chatfield, M. et. al. (2017). Evaluating Progress in Analytical Quality by Design. Pharmaceutical Technology, 41 (4), 52–59.
Magnusson, B., Örnemark, U. (Eds.) (2014). The Fitness for Purpose of Analytical Methods – A Laboratory Guide to Method Validation and Related Topics. Eurachem, 70.
Bettencourt da Silva, R., Williams, A. (Eds.) (2015). Setting and Using Target Uncertainty in Chemical Measurement. Eurachem/CITAC, 30.
Leontiev, D., Volovyk, N. (2016). Specificity of application of the uncertainty concept to the decision on compliance of medicines. Arhiv za farmaciju, 66, 207–208.
The State Pharmacopoeia of Ukraine. Vol 2, Suppl. 4 (2020). Kharkiv: State Enterprise «Ukrainian Scientific Pharmacopoeial Centre for Quality of Medicines».
Gryzodub, O., Leontiev, D., Denisenko, N., Podpruznikov, Y. (2004). Standardised procedure of validation of assay procedures by the method of standard. Farmacom, 3, 3–17.
The State Pharmacopoeia of Ukraine. Vol 1, Suppl. 1 (2004). Kharkiv: State Enterprise «Ukrainian Scientific Pharmacopoeial Centre for Quality of Medicines».
<1220> Analytical Procedure Lifecycle (2020). Pharmacopeial Forum, 46 (5). Available at: https://online.usppf.com/usppf
Barnet, K., McGregor, P., Martin, G. P., et. al. (2017). Analytical Target Profile: Structure and Application Throughout the Analytical Lifecycle. Pharmacopeial Forum, 42 (5). Available at: http://www.usppf.com/pf/pub/index.html
Takano, D. E. N., de Souza Reis, P. R., Singh, A. K., Lourenço, F. R. (2017). Estimation of uncertainty for measuring desloratadine in tablets formulation using UV spectrophotometry. Measurement, 101, 40–44. doi: http://doi.org/10.1016/j.measurement.2017.01.018
Gryzodub, O. (2016). Standardised validation schemes for drug quality control procedures. Kharkiv: State Enterprise «Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines», 396.
<1200> Requirements for Compendial Validation (2014). Pharmacopeial Forum, 39 (6). Available at: http://www.usppf.com/pf/pub/index.html
Copyright (c) 2020 Dmytro Leontiev, Vasyl Petrus, Natalia Volovyk, Oleksandr Gryzodub
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
